CLDN18 and gastric cancer: Tumor biogenesis is a complex progress involving multiple genes, and HOXC10 (22), UFM1 (23), EGR1 (24), MDGA2 (25), and CLDN18 (26) have been proved to be biomarkers of GC, but the pathogenesis and mechanism of GC have not been clarified.